ConforMIS is a medical technology company that uses its proprietary iFitÂŽ Image-to-ImplantÂŽ technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patientâs unique anatomy. ConforMIS offers a broad line of customized knee implants designed to restore the natural shape of a patientâs knee. In recent clinical studies, iTotalÂŽ CR, ConforMISâ cruciate-retaining total knee replacement implant and best-selling product, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints and other elements of the iFitÂŽ Image-to-ImplantÂŽ technology platform. ConforMIS believes its iFitÂŽ Image-to-ImplantÂŽ technology platform has application to other major joints in the worldwide market for joint replacement products. Source
No articles found.
Eiger is a late stage biopharmaceutical company focused on the development and com...
Eiger is a late stage biopharmaceutical company...
ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to...
ILLUSIO is a plastic surgery simulation tool th...
Admedus Limited is a bio medical group. The Group commercializes tissue engineerin...
Admedus Limited is a bio medical group. The Gro...
Applied Science Products operates Advanced Plasma Products, Inc., a science and en...
Applied Science Products operates Advanced Plas...
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on deve...
Aptevo Therapeutics Inc. is a clinical-stage bi...
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated t...
electroCore, Inc. is a commercial stage bioelec...
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, an...
Shionogi & Co., Ltd. engages in the research, d...
Join the National Investor Network and get the latest information with your interests in mind.